| Name | Title | Contact Details |
|---|
Pioneering the discovery and development of RNA-based therapeutics designed to prevent, repair and reverse diseases of the heart.
Ophthotech is a biopharmaceutical company specializing in the development of novel therapeutics to treat back of the eye diseases, with a focus on developing innovative therapies for age-related macular degeneration (AMD). Ophthotech`s most advanced product candidate, Fovista® anti-PDGF therapy, is in Phase 3 clinical trials for use in combination with anti-VEGF therapy that represents the current standard of care for the treatment of wet AMD. Ophthotech`s second product candidate, Zimura®, an inhibitor of complement factor C5, is being developed for the treatment of geographic atrophy, a form of dry AMD.
RSA Americas is a Morristown, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Pinnacle Pharmaceutics Ltd is a Whitby, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Anuncia Medical, Inc., an emerging leader in Cerebrospinal Fluid (CSF) management